Grupo Ferrer acquires Alexza for up to $55mm
Executive Summary
Per a non-binding letter of intent, private Spanish company Grupo Ferrer Internacional SA aims to acquire all shares of public US biotech Alexza Pharmaceuticals Inc. (CNS therapeutics) that it doesn't already own.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice